New Report Assesses Pipelines for Eye Infection Drugs
Posted on: Thursday, 12 July 2007, 09:19 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c62515) has announced the addition of Ophthalmology and Optometry - Eye Infections Drug Pipeline Report to their offering.
"Ophthalmology and Optometry - Eye Infections Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of eye infections drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
UPCOMING PATENT EXPIRES BY THERAPY AREA
Eye Infections Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Legend
--Top 20 companies in late stage Eye Infections Projects
--Top 20 companies in early stage Eye Infections Projects
Full Pipeline View
--Phase II Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c62515
Source: Life Science Analytics
Source: Business Wire
Related Articles
- ALS Therapy Development Institute, the World's Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer
- Heartland Oil and Gas Continues Production Enhancement and Well and Pipeline Expansion Projects in Texas and Kansas
- New Victrex PEEK Film Technology APTIV Product Name Created By Strategic Name Development
- BP Launches Open Season on Proposed Pipeline Reversal Project to Bring Light Canadian Crude to Cushing
- NDS Surgical Imaging Launches New Product Lines, Enters Infection Control Markets - Expansion Demonstrates Company's Commitment to Patient Safety in Surgical and Imaging Markets
- Energy Transfer Partners, L.P. Continues Timely Completion of 42-Inch Pipeline Construction Project
- Energy Transfer Partners, L.P. Announces Completion of First Phase of 42-Inch Pipeline Expansion Project
- BP May Resume Alaskan Pipeline Production Soon
- Despite Heightened Concerns Over Influenza, the Most Commercially Important Viral Infections for Drug Developers Remain HIV, Hepatitis C, and Hepatitis B
- Russia, Sweden To Enact Clean Production Project
 |
 |
User Comments (0)
RSS Feeds